Australia's largest stock trading and investment forum Australia's #1 stock forum

SDL

Click for more information

0.00%

0.6¢ sundance resources limited

Hi squidd. That is what I have been saying all along, not C1...

First 45 Last

Share
Profile

Follow
westcott

8,602 Posts.

40

01/05/15

10:20

Post #: 15196618
Share

Originally posted by squidd ↑

Hi westcott,

C1 costs are reported to inform investors and the market about pure mining efficencies. C1 costs are not supposed to be used to evaluate overall profitability of a business.

If all you want to talk about is overall profitability, that's fine, simply ignore C1 cost reporting as it is not relevant to you. It is, however, a valid measure.

For many years you were very happy to quote SDL's OPEX 0f $22 without stating that this figure did not include shipping costs, debt repayments etc.

It is up to the investor to know the difference between the different measures, and what those measures are used for. Just because you don't want to use C1 costs / OPEX anymore, does not mean the measure is invalid.

Cheers!

PS. It's going to be interesting to see what happens to the Hanlong shares, hopefully news this quarter. If SDL doesn't want to deal with the dilution / survival question of another working capital injection, it needs to move quickly to secure strategic partners and debt funding.

Expand

Hi squidd.

That is what I have been saying all along, not C1 costs, share holders need All costs included to see if it is profitable, C1 does not do that, why is that so hard to understand with you?

Westcott.
Away for a few days at a wedding.

SDL Price at posting: 2.1¢ Sentiment: None Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

The iron ore comeback: Can it last?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HAS

Hastings progressing Yangibana to production with lower costs

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 17 more messages in this thread...

First 45 Last

Add SDL (ASX) to my watchlist